Gemlapodect

DB18769InvestigationalSmall molecule

Gemlapodect: Overview.

Mechanism: Pharmacologically active on cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A and Phosphodiesterase
Curator reviewed
Formula / weight: C₂₂H₂₁N₇O₃ · 431.456 g/mol (avg)
Code names: NOE-105

Resolves to

Compound

Structure

InChIKeyMMCSMWHWVGGCGL-UHFFFAOYSA-NSMILESCN1N=CC(C(=O)N2CCOCC2)=C1C(=O)NC1=CC2=NC(=NN2C=C1)C1=CC=CC=C1

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gemlapodect, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.